Neogen (NEOG) Competitors $11.56 -0.04 (-0.34%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NEOG vs. MMSI, HAE, ICUI, XRAY, QDEL, STAA, CERS, OSUR, ANIK, and UTMDShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry. Neogen vs. Merit Medical Systems Haemonetics ICU Medical DENTSPLY SIRONA QuidelOrtho STAAR Surgical Cerus OraSure Technologies Anika Therapeutics Utah Medical Products Merit Medical Systems (NASDAQ:MMSI) and Neogen (NASDAQ:NEOG) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking, media sentiment and dividends. Is MMSI or NEOG more profitable? Merit Medical Systems has a net margin of 9.05% compared to Neogen's net margin of -2.58%. Merit Medical Systems' return on equity of 15.61% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Merit Medical Systems9.05% 15.61% 8.38% Neogen -2.58%2.80%1.93% Does the MarketBeat Community prefer MMSI or NEOG? Merit Medical Systems received 106 more outperform votes than Neogen when rated by MarketBeat users. Likewise, 69.48% of users gave Merit Medical Systems an outperform vote while only 56.68% of users gave Neogen an outperform vote. CompanyUnderperformOutperformMerit Medical SystemsOutperform Votes43769.48% Underperform Votes19230.52% NeogenOutperform Votes33156.68% Underperform Votes25343.32% Which has more volatility and risk, MMSI or NEOG? Merit Medical Systems has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Neogen has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Do insiders and institutionals hold more shares of MMSI or NEOG? 99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 3.7% of Merit Medical Systems shares are held by insiders. Comparatively, 1.1% of Neogen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts recommend MMSI or NEOG? Merit Medical Systems presently has a consensus target price of $107.70, indicating a potential upside of 4.66%. Neogen has a consensus target price of $16.25, indicating a potential upside of 40.57%. Given Neogen's higher possible upside, analysts plainly believe Neogen is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00Neogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has preferable earnings & valuation, MMSI or NEOG? Merit Medical Systems has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMerit Medical Systems$1.26B4.77$94.41M$2.0450.44Neogen$924.22M2.71-$9.42M-$2.19-5.28 Does the media refer more to MMSI or NEOG? In the previous week, Merit Medical Systems had 2 more articles in the media than Neogen. MarketBeat recorded 13 mentions for Merit Medical Systems and 11 mentions for Neogen. Merit Medical Systems' average media sentiment score of 1.07 beat Neogen's score of 0.67 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 6 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neogen 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMerit Medical Systems beats Neogen on 16 of the 18 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.68B$2.36B$5.24B$8.98BDividend YieldN/A0.68%5.13%4.03%P/E RatioN/A2.6561.7913.70Price / Sales2.7183.711,258.3278.91Price / Cash12.0616.6543.8235.97Price / Book0.803.345.324.80Net Income-$9.42M$29.98M$122.68M$224.91M7 Day Performance-6.47%-3.08%-0.21%1.47%1 Month Performance-0.69%-2.42%3.72%4.66%1 Year Performance-31.96%-16.42%27.18%20.83% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.4507 of 5 stars$11.56-0.3%$16.25+40.6%-31.5%$2.68B$924.22M-5.282,640Earnings ReportInsider TradeHigh Trading VolumeMMSIMerit Medical Systems4.6119 of 5 stars$95.70-0.5%$107.70+12.5%+32.0%$5.58B$1.33B46.916,950Analyst ForecastNews CoverageHAEHaemonetics4.4869 of 5 stars$79.53+3.7%$108.78+36.8%-10.9%$3.99B$1.36B33.003,657ICUIICU Medical4.16 of 5 stars$157.72+2.2%$199.67+26.6%+76.1%$3.86B$2.34B-34.5114,000Short Interest ↑XRAYDENTSPLY SIRONA4.8223 of 5 stars$18.83+3.9%$27.27+44.8%-47.2%$3.74B$3.90B-9.1015,000QDELQuidelOrtho4.5049 of 5 stars$44.69-2.3%$53.43+19.6%-40.9%$3.01B$2.82B-1.607,100Positive NewsSTAASTAAR Surgical4.7843 of 5 stars$22.42-2.5%$42.83+91.0%-24.4%$1.10B$341.22M50.951,115Insider TradeNews CoverageCERSCerus2.4274 of 5 stars$1.67+5.4%$3.63+117.7%+7.8%$309.22M$176.23M-15.14290Short Interest ↑OSUROraSure Technologies4.4121 of 5 stars$3.70+2.2%$5.50+48.6%-55.1%$276.00M$224.26M24.67840Analyst UpgradeNews CoverageANIKAnika Therapeutics3.5752 of 5 stars$15.89+2.1%$24.50+54.2%-28.4%$232.73M$164.17M-2.39300Positive NewsUTMDUtah Medical Products3.0044 of 5 stars$61.28+0.6%N/A-23.5%$207.86M$44.08M14.35180News CoveragePositive News Related Companies and Tools Related Companies MMSI Competitors HAE Competitors ICUI Competitors XRAY Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors ANIK Competitors UTMD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NEOG) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
